February 8, 2025 - This provides direct experimental support for the Type 3 Diabetes hypothesis, reinforcing the idea that Alzheimer’s disease is a brain-specific form of insulin resistance. The study showed that when insulin signaling is disrupted in the brain, neurons become starved for energy, oxidative stress increases, and key pathological features of AD—including tau tangles and amyloid plaques—begin to develop.

November 7, 2024 - Recent research has proposed a novel conceptualization of AD as “type 3 diabetes”, highlighting the critical roles of insulin resistance and impaired glucose metabolism in the pathogenesis of the disease.

November 25, 2025 - This form of diabetes is associated with Alzheimer's disease. Type 3 diabetes occurs when neurons in the brain become unable to respond to insulin, which is essential for basic tasks, including memory and learning.

November 7, 2024 - Recent research has proposed a novel conceptualization of AD as "type 3 diabetes", highlighting the critical roles of insulin resistance and impaired glucose metabolism in the pathogenesis of the disease.

November 5, 2025 - Type 3 diabetes (T3D) is characterized by chronic insulin resistance and insulin deficiency in the brain, leading to neuronal death, inflammation, oxidative stress, apoptosis, and synaptic dysfunction.

June 30, 2024 - There were some clinical symptoms of AD in diabetes patients, such as memory processing, morphology of brain and synaptic communication, owing to brain insulin resistance and regional cerebral glucose metabolism similar to AD (Baker et al., 2011; Gordon et al., 2018), especially in hippocampus (Ferreira et al., 2018; Rorbach-Dolata and Piwowar, 2019).Insulin resistance in the brain caused Aβ and its precursor toxicity to increase, Tau hyperphosphorylation, oxidative stress, and neuroinflammation, leading to neurodegeneration and the eventual emergence of AD.

November 14, 2024 - Insulin resistance in the brain is at the heart of type 3 diabetes research. When your brain stops responding to insulin or using it well, this could set the stage for many of the same issues as above, like inflammation and blocked nerve communication...

More importantly, in AD, the deficits ... and T2DM, respectively. Consequently, the coexistence of both conditions in AD has led to the conceptualization of AD as a unique form of brain-dominant diabetes, referred to as “T3DM” (de la Monte and Wands 2008; de la Monte ...

August 27, 2025 - Alzheimer’s disease (AD) is increasingly associated with metabolic dysfunction, particularly insulin resistance, which impairs neuronal signaling and energy metabolism. Disruption of brain insulin pathways contributes to amyloid-beta accumulation, ...

October 18, 2023 - Alzheimer Associated Diabetes Mellitus, commonly known as Type 3 Diabetes Mellitus (T3DM) is a distinct subtype of diabetes with a pronounced association with Alzheimer's disease (AD).

April 20, 2022 - In particular, glucose metabolism impairment has demonstrated to be a key regulatory element in the onset and progression of AD, which is why nowadays AD is considered the type 3 diabetes.

Brain insulin and IGF deficiency and resistance increase with progression of AD. Postmortem histopathological studies categorized the brains as having normal aging (Braak 0–1), or mild (Braak 2–3), moderate to severe (Braak 4–5), or end-stage ...

April 30, 2020 - However, poorly controlled blood sugar may increase the risk of developing Alzheimer's. This relationship is so strong that some have called Alzheimer's "diabetes of the brain" or "type 3 diabetes (T3D)". Given more recent studies continue to ...

Type 3 diabetes, a term that underscores the pathological connection between Type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), emphasizes the role of cerebral insulin resistance and metabolic dysfunction in neuron degeneration.

February 28, 2022 - Oligomers are toxic to nerve cells, while misfolded oligomers can transmit the wrong folding to their neighbors acting as prions [44,45,46,47]. The aggregation of the amyloid peptide into oligomers or fibrils, in turn, is involved in the progression of AD [48]. Reduced levels of IGF-1(insulin-like growth factor) [49] and insulin resistance may result in reduced IGF-1 and insulin brain uptake, causing β-amyloid accumulation. Consequently, increased β-amyloid levels antagonize insulin and IGF-1 receptor binding, which results in the secretion of inflammatory agents and the onset of insulin resistance [50]. Moreover, these factors of insulin dysfunction and inflammation, in combination with oxidative stress, enhance the toxicity and concentration of β-amyloid [51] in a pathological feedback cycle.

May 20, 2010 - Overview: There appear to be many ... utilization and energy metabolism.6,19 As T2DM is associated with peripheral insulin resistance, AD is associated with brain insulin resistance.20 Early in AD, there seems to be inadequate ...

May 5, 2020 - The concept of Type 3 diabetes comes from the idea that insulin resistance is linked, in many cases, to Alzheimer's dementia, making it yet another form of diabetes. Of course, the term is also an oversimplification, says Dr.

January 5, 2026 - In short, research suggests that in some cases, insulin resistance and these other disruptions of the metabolism may occur “upstream” –— before the brain develops amyloid plaques and tau tangles that are both associated with Alzheimer’s disease — and “increase the risk of these toxic proteins building up,” Carlisle said. Both Dabelea and Carlisle say “no,” it’s not accurate to characterize diabetes in people who also have Alzheimer’s disease as Type-3 diabetes.